Last reviewed · How we verify
NCT05111977
Gastrointestinal Interoception in Anorexia Nervosa
NA trial testing Vibrant capsule in Anorexia Nervosa in 150 participants. Currently enrolling.
30 April 2026
Quick facts
| Lead sponsor | Laureate Institute for Brain Research, Inc. |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 150 |
| Start date | 1 December 2021 |
| Primary completion | 30 April 2026 |
| Estimated completion | 31 July 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Vibrant capsule
Conditions studied
- Anorexia Nervosa — all drugs for Anorexia Nervosa →
Sponsor
Laureate Institute for Brain Research, Inc.
Who can join
Adults 15 to 40, female only, with Anorexia Nervosa. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Anorexia nervosa (AN) has among the highest mortality rate of any psychiatric illness, yet we have a poor understanding of the biological causes of this disorder. In this study, we use a novel mechanosensory intervention to examine the basic question of whether individuals with AN have abnormal "gut sensations" and whether such indicators are associated with adverse consequences from the disorder.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05111977
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vibrant capsule
Trials testing the same drug.
- NCT05036369 — Vibrant Capsule vs. Placebo for Patient Suffering From Constipation · NA · completed
- NCT04458675 — Efficacy and Safety of Vibrant Capsule vs. Vibrant Placebo for the Treatment of Chronic Idiopathic Constipation (CIC) · Phase 4 · completed
- NCT03031301 — A Study to Assess the Efficacy and Safety of the Vibrant Capsule Administered 5 Times Per Week · NA · completed
Other recruiting trials for Anorexia Nervosa
Currently open trials in the same condition.
- NCT07169747 — Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young · Phase 2 · recruiting
- NCT07237607 — Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders · NA · recruiting
- NCT07188155 — Adapting Exposure for Adolescent AN · NA · recruiting
- NCT07143981 — The Fecal Microbiome Transplant (FMT) Study for Anorexia Nervosa · recruiting
- NCT07311356 — Prognosis of Early-onset Anorexia Nervosa · recruiting
Other Laureate Institute for Brain Research, Inc. trials
Trials by the same sponsor.
- NCT06410196 — Mood and Decision-making in Methamphetamine Use Disorder · NA · recruiting
- NCT06088732 — Effects of Acute Exercise and Ibuprofen on Symptoms, Immunity, and Neural Circuits in Bipolar Depression · Phase 1, PHASE2 · recruiting
- NCT06219681 — Modulating Repetitive Negative Thinking Related Brain Networks in Young Adults With Depression · NA · terminated
- NCT06004115 — Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression · Phase 4 · recruiting
- NCT06486584 — Contingency Management for Problematic Behavior Reduction in the Community · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05111977 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Laureate Institute for Brain Research, Inc.
- Last refreshed: 10 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05111977.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing